Xylyx Bio, Inc.

Apr 02, 2025

Xylyx Bio receives $1.125 million from multiple foundations to accelerate clinical translation of bioengineered human organs for life-saving transplantation

Sep 16, 2024

Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease

Jun 14, 2024

Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute

Feb 02, 2021

Xylyx Bio and Cell&Soft Announce positive initial results following Strategic Partnership to Develop Next-Generation in vitro Platforms to Accelerate Cancer Drug Discovery

Sep 29, 2020

XYLYX BIO launches specialized contract R&D services that increase predictiveness in antifibrotic drug discovery

Aug 26, 2020

XYLYX BIO releases highly physiologic 2D substrates for improved antifibrotic drug discovery

May 27, 2020

Xylyx Bio releases advanced disease model system to improve cancer drug discovery

Apr 15, 2020

Xylyx Bio offers advanced lung models to accelerate COVID-19-related drug development